Episódios

  • Diagnosis and Treatment of Acute Ischemic Stroke
    Nov 12 2026

    Ischemic stroke is a leading cause of disability and death and accounts for about 85% of strokes in the US. Author Gregory Albers, MD, of Stanford University Medical Center joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the diagnosis and treatment of ischemic stroke.

    Related Content:

    • Treatment of Acute Ischemic Stroke
    Exibir mais Exibir menos
    13 minutos
  • Idiosyncratic Drug-Induced Liver Injury: Diagnosis, Risk Factors, and Management
    Nov 4 2026

    Idiosyncratic drug-induced liver injury is damage caused by prescription or over-the-counter medications or herbal dietary supplements that is not dose-dependent. JAMA Associate Editor Beverly Forsyth, MD, speaks with author Naga Chalasani, MD, of Indiana University School of Medicine about risk factors, evaluation, and treatment of patients with idiosyncratic drug-induced liver injury.

    Related Content:

    • Idiosyncratic Drug-Induced Liver Injury
    • Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data
    Exibir mais Exibir menos
    17 minutos
  • Diagnosis and Management of Childhood Obesity
    Oct 21 2026

    Childhood obesity affects approximately 15% of children aged 2 to 12 and is associated with adverse health outcomes in adulthood. Author Claudia K. Fox, MD, MPH, of the University of Minnesota Medical School joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss epidemiology, diagnosis, and treatment of childhood obesity.

    Related Content:

    • Obesity in Children Aged 2 to 12 Years
    Exibir mais Exibir menos
    18 minutos
  • Heart Transplant for Advanced Heart Failure
    Oct 12 2026

    Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author JoAnne Lindenfeld, MD, of Vanderbilt University joins JAMA Associate Editor David Simel, MD, MHS, to discuss indications, transplant evaluation, management after transplant, long-term complications, and survival.

    Related Content:

    • Heart Transplant for Advanced Heart Failure
    Exibir mais Exibir menos
    23 minutos
  • Narcolepsy: A Review
    Oct 5 2026

    Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom Scammell, MD, of Harvard Medical School joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the etiology, clinical presentation, diagnostic evaluation, and treatment of narcolepsy.

    Related Content:

    • Narcolepsy
    • The Orexin System—A Key Component of Sleep Regulatory Networks and Involvement in Narcolepsy
    Exibir mais Exibir menos
    21 minutos
  • Influenza, RSV, and COVID-19 Vaccines: Effectiveness, Safety, and Trust in 2026
    Sep 30 2026

    Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and recommendations. JAMA Deputy Editor Preeti Malani, MD, MSJ, speaks with Rochelle Walensky, MD, MPH, professor of medicine at Harvard Medical School and former CDC Director, about vaccine data, public trust, and the 2026 respiratory virus season.

    Related Content:

    • Respiratory Season Virus Vaccines
    • RSV Immunization Effectiveness and Safety for the 2026-2027 Respiratory Season
    • Influenza Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season
    • COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season
    Exibir mais Exibir menos
    14 minutos
  • Vaccines for Cancer Treatment
    Sep 21 2026

    Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction of cancer cells. Several vaccines are approved and others are in development for cancer treatment. Author Nora Disis, MD, JAMA Deputy Editor and Editor in Chief of JAMA Oncology, discusses cancer vaccines and more with JAMA Deputy Editor Mary McDermott, MD.

    Related Content:

    • Vaccines for Cancer
    Exibir mais Exibir menos
    20 minutos
  • Idiopathic Normal Pressure Hydrocephalus: Diagnosis and Treatment
    Sep 14 2026

    Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and is associated with gait impairment, cognitive decline, and urinary dysfunction. Author Mark G. Luciano, MD, PhD, from Johns Hopkins University, discusses this and more with JAMA Deputy Editor Kristin Walter, MD, MS.

    Related Content:

    • Idiopathic Normal Pressure Hydrocephalus
    Exibir mais Exibir menos
    19 minutos